Medical News Feed
German Drug Data (Deutsch)
Norwegian Drug Data (Norge)
Netherlands Drug Data (Nederlands)
Swedish Drug Data (Sverige)
Want to submit or suggest content for the epgonline.org YouTube Clinical channel?
Contact us here
epgonline.org is not responsible for content on any 3rd party website
Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.
| Drug class description : | Progestogens. |
| Generic Name : | Etonogestrel |
| Drug description : | Non-biodegradable white to off- white flexible rod for subdermal use. |
| Presentation : | Subdermal implant, etonogestrel 68mg. Release rate is 60 - 70 microgram per day in week five to six and has decreased to approximately 35 - 45 microgram per day at the end of the first year, to approximately 30 - 40 microgram per day at the end of the second year and to approximately 25 - 30 microgram per day at the end of the third year. |
| Indications : | Long-term reversible contraception. (Safety and efficacy have been established in women between 18 and 40 years of age.) |
| Adult Dosage : | Over 18 years and under 40 years: one implant is inserted subdermally. Maximum duration of use per implant, three years. For insertion and removal techniques refer to the product information. Additional information and more detailed instructions concerning detailed instructions concerning insertion and removal will be sent on request free of charge by Organon (tel: 01223 432700). |
| Child Dosage : | Not recommended. |
| Contra Indications : | Active venous thromboembolic disorder. Progestogen-dependent tumours. Presence or history of severe hepatic disease as long as liver function values have not returned to normal. Known or suspected pregnancy. Undiagnosed vaginal bleeding. Hypersensitivity to any of the components of Implanon. |
| Special Precautions : | In women being treated with enzyme-inducing drugs it is recommended to advise the additional temporary use of a barrier method or prescribe another non-hormonal contraceptive method. Remove implant in the event of a thrombosis. Long-term immobilisation - consider removal. History of thromboembolic disorders. Diabetes. Tendency to chloasma. Earlier replacement of implant may be required in heavier women. If amenorrhoea or abdominal pain occur, consider ectopic pregnancy. History during pregnancy or previous use of sex steroids of jaundice, pruritus related to cholestasis, gallstones, porphyria, SLE, haemolytic uraemic syndrome, Sydenham's chorea, herpes gestationis, otosclerosis. Monitor blood pressure. Lactation. |
| Interactions : | Hydantoins, barbituarates, primidone, carbamazepine, rifampicin, rifabutin, enzyme- inducing drugs. |
| Adverse Reactions : | Acne, headache, increase in body weight, breast tenderness and pain. Less frequently, alopecia, depressive moods, emotional lability, changes in libido, abdominal pain, dysmenorrhoea. Rarely, rise in blood pressure. Insertion or removal may cause some bruising, slight local Occasionally a scar will be |
| Manufacturer : | Organon |
| Drug Availability : | (POM) |
Only registered users have access to the full EPG Online Knowledge Base including drug search tools, interactive disease Knowledge Centres via the EPG Knowledge Library - with clinical and evidence based physician and research tools, MiMedia (build your own clinical media collection with everything from key opinion leader essays to mode of action videos and other multi-media content), the EPG Survey panel, health news updates and much much more.
Already Registered?
Please log-in now using our member login box.
Not a member?
Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students.
Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major therapeutic areas, disease management, and clinical tools.
As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!
REGISTER today it only takes a minute! and it's FREE
Having problems?
Use our forgotten password facility or email us at: contact@epgonline.org